Neonatal drug therapy: The first frontier of therapeutics for children-Reference-Cited by-同舟云学术

Neonatal drug therapy: The first frontier of therapeutics for children

Published:2015-07-22 Issue:3 Volume:98 Page:288-297
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Allegaert K¹²,van den Anker J³⁴⁵⁶

Affiliation:

1. Neonatal Intensive Care Unit; University Hospitals Leuven; Leuven Belgium

2. Department of Development and Regeneration; KU; Leuven Belgium

3. Division of Pediatric Clinical Pharmacology; Children's National Health System; Washington DC USA

4. Departments of Pediatrics; Integrative Systems Biology; Pharmacology and Physiology; George Washington University School of Medicine and Health Sciences; Washington DC USA

5. Intensive Care and Department of Pediatric Surgery; Erasmus MC - Sophia Children's Hospital; Rotterdam the Netherlands

6. Department of Paediatric Pharmacology; University Children's Hospital Basel; Basel Switzerland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference64 articles.

1. Developmental pharmacology-drug disposition, action, and therapy in infants and children.;Kearns;N. Engl. J. Med.,2003

2. Adverse drug reactions in neonates and infants: a population-tailored approach is needed;Allegaert;Br. J. Clin. Pharmacol.,2014

3. Impact of perinatal corticosteroids on neuromotor development and outcome: review of the literature and new meta-analysis.;Shinwell;Semin. Fetal Neonatal Med.,2009

4. Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies.;Saugstad;Neonatology,2014

5. Drug metabolism for the paediatrician.;Wildt;Arch. Dis. Child.,2014

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interdisciplinary Collaboration on Real World Data to Close the Knowledge Gap: A Reflection on “De Sutter et al. Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling”;Pharmaceutics;2024-01-19

3. Neonatal Pharmacology;Avery's Diseases of the Newborn;2024

4. Challenges of pediatric pharmacotherapy: A narrative review of pharmacokinetics, pharmacodynamics, and pharmacogenetics;European Journal of Clinical Pharmacology;2023-12-11

5. Need for larger cohorts and standardized tools to study diseases in newborn infants;Newborn;2023-09-25